Pulmonary Artery News and Research

RSS
BMPR2 mutations affect outcomes of PAH patients

BMPR2 mutations affect outcomes of PAH patients

Tricuspid regurgitation tied to outcomes in PAH patients

Tricuspid regurgitation tied to outcomes in PAH patients

Regulatory immune cells compromised in PAH

Regulatory immune cells compromised in PAH

CHLA cardiologists perform rare fetal cardiac intervention procedure

CHLA cardiologists perform rare fetal cardiac intervention procedure

BMPR2 mutations affect outcomes of PAH patients

BMPR2 mutations affect outcomes of PAH patients

Study findings may help explain why risk of stroke changes after menopause

Study findings may help explain why risk of stroke changes after menopause

New blood biomarkers could lead to better evaluation of treatment for patients with PAH

New blood biomarkers could lead to better evaluation of treatment for patients with PAH

RV glucose metabolism changes associated with RV function

RV glucose metabolism changes associated with RV function

Early promise for pulmonary artery denervation in PAH patients

Early promise for pulmonary artery denervation in PAH patients

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Mallinckrodt announces approval of INOmax for cardiovascular surgery in Australia and Japan

Scientists compile complete genetic information of people affected by PAH

Scientists compile complete genetic information of people affected by PAH

Arterial shunt in hybrid palliation better for hypoplastic left heart syndrome treatment

Arterial shunt in hybrid palliation better for hypoplastic left heart syndrome treatment

Study reveals benefit of early screening for vascular disorder patent ductus arteriosus among preterm infants

Study reveals benefit of early screening for vascular disorder patent ductus arteriosus among preterm infants

Mount Sinai cardiologists implant microchip sensors to better monitor patients with heart failure

Mount Sinai cardiologists implant microchip sensors to better monitor patients with heart failure

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

Physicians at UH Case Medical Center implant revolutionary device to treat right ventricular heart disease

Early intensive epoprostenol yields best haemodynamic outcomes in PAH

Early intensive epoprostenol yields best haemodynamic outcomes in PAH

Meta-analysis supports ambrisentan efficacy

Meta-analysis supports ambrisentan efficacy

Selten Pharma's SPI-026 granted FDA Orphan Drug Designation for treatment of PAH

Selten Pharma's SPI-026 granted FDA Orphan Drug Designation for treatment of PAH

Combining CT measurements assists pulmonary hypertension prediction

Combining CT measurements assists pulmonary hypertension prediction

Metabolic derangement may facilitate cell proliferation in PAH

Metabolic derangement may facilitate cell proliferation in PAH